EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Corynebacterium striatum infections in oncologic patients: clinical spectrum, resistance profiles, and evidence of nosocomial transmission

Kenya Yukawa, Sohei Harada iD, Kohji Komori, Brian Hayama, Daisuke Ohkushi, Koichi Takeda, Taisuke Enokida, Akira Yarimizu, Kazumi Takehana, Kageto Yamada iD, Michihiko Goto, Kazuhiro Tateda

Journal of Clinical Microbiology · 2025

DOI: 10.1128/jcm.00829-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Microbiology, 2025. Verfasst von Kenya Yukawa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Infectious Diseases, Toho University Graduate School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Corynebacterium, Corynebacterium Infections, Cross Infection, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Among Corynebacterium species, Corynebacterium striatum is relatively frequently involved in invasive human infections. In this study, we collected clinical information from patients diagnosed with C. striatum infection at a single cancer center and performed antimicrobial susceptibility testing and whole-genome sequencing of the causative strains. Of the 51 patients with C. striatum infections, 15 (29.4%) had postoperative intra-abdominal infections, eight (15.7%) had postoperative skin and soft tissue infections of the neck, and eight (15.7%) had osteoarticular infections. In 15 patients, C. striatum was detected concomitantly with other bacteria. The median duration of antimicrobial therapy was 25 days, with 43 patients (84.3%) showing clinical improvement by day 14. The crude mortality up to 90 days post-diagnosis was 15.7%. Vancomycin was the most commonly used definitive therapy, and 40 patients (78.4%) received multiple antimicrobial agents. Oral minocycline was often administered in patients requiring long-term treatment. Antimicrobial susceptibility testing of 53 strains, including two strains from follow-up cultures from the same patient, showed that most strains were susceptible to daptomycin and tetracyclines. However, non-susceptibility was noted in two strains (3.8%) for daptomycin and four strains (7.5%) for tetracyclines, each associated with psgA2 mutation and tet (W) carriage. Core-genome single-nucleotide polymorphism analysis of the strains and epidemiological reviews of the source patients identified three suspected clusters of nosocomial transmission involving seven patients. This study demonstrated that C. striatum can cause a range of infections in patients with underlying diseases, such as malignancy, and that nosocomial spread of this pathogen may also occur. IMPORTANCE The use of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, employed for bacterial species identification in this study, has enhanced the recognition of Corynebacterium striatum as an important human pathogen in clinical microbiology laboratories. Our study demonstrated that C. striatum is associated with various healthcare-associated infections, including those requiring prolonged antimicrobial therapy, and that nosocomial transmission of this pathogen can result in the development of infections. In addition, several agents other than vancomycin, such as teicoplanin, tetracyclines, and trimethoprim/sulfamethoxazole, have demonstrated favorable activities. The results of this study indicate the need for further research on the mechanisms and modes of nosocomial transmission of C. striatum , as well as the clinical efficacy of alternative agents to vancomycin, particularly those suitable for prolonged treatment, given the potential side effects associated with vancomycin use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CorynebacteriumCorynebacterium InfectionsCross InfectionNeoplasmsHumansMaleFemaleMiddle AgedAnti-Bacterial AgentsAgedMicrobial Sensitivity TestsAdultWhole Genome SequencingAged, 80 and overYoung AdultDrug Resistance, Bacterial

Stichwörter der Autor:innen

Corynebacterium striatumnosocomial transmissionwhole-genome sequencing

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Microbiology and Infectious Diseases, Toho University Graduate School of Medicine, Tokyo, Japan.
  • Department of Infectious Diseases, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo, Japan.
  • Division of Collaborative Regional Infection Control, Department of Community Well-being, Toho University School of Medicine, Tokyo, Japan.
  • Clinical Laboratories, Cancer Institute Hospital, Japanese Foundation For Cancer Research, Tokyo, Japan.
  • Division of Infectious Diseases, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.

ORCID-Profile: Sohei Harada, Kageto Yamada

Zitieren

APA

Yukawa, K., Harada, S., Komori, K., Hayama, B., Ohkushi, D., Takeda, K., Enokida, T., Yarimizu, A., Takehana, K., Yamada, K., Goto, M., & Tateda, K. (2025). Corynebacterium striatum infections in oncologic patients: clinical spectrum, resistance profiles, and evidence of nosocomial transmission. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.00829-25

Vancouver

Yukawa K, Harada S, Komori K, Hayama B, Ohkushi D, Takeda K, et al. Corynebacterium striatum infections in oncologic patients: clinical spectrum, resistance profiles, and evidence of nosocomial transmission. Journal of Clinical Microbiology. 2025. doi:10.1128/jcm.00829-25

BibTeX
@article{Yukawa2025,
  author = {Yukawa, Kenya and Harada, Sohei and Komori, Kohji and Hayama, Brian and Ohkushi, Daisuke and Takeda, Koichi and Enokida, Taisuke and Yarimizu, Akira and Takehana, Kazumi and Yamada, Kageto and Goto, Michihiko and Tateda, Kazuhiro},
  title = {Corynebacterium striatum infections in oncologic patients: clinical spectrum, resistance profiles, and evidence of nosocomial transmission},
  journal = {Journal of Clinical Microbiology},
  year = {2025},
  doi = {10.1128/jcm.00829-25}
}
Kostenlos starten →